DxS and Wellcome Trust partner for B-RAF test
This article was originally published in Clinica
Executive Summary
In a bid to improve the detection of the V600E B-RAF mutation, UK personalised medicine specialist DxS is set to provide medical research foundation The Wellcome Trust with a test for use in clinical trials.